Tuberculosis Risk Before and After Highly Active Antiretroviral Therapy Initiation: Does HAART Increase the Short-term TB Risk in a Low Incidence TB Setting?

Documenti analoghi

• Timing of Antiretroviral Treatment, Immunovirologic Status and TB Risk: Implications for Test and Treat
  di: PETTIT, April C., et al.
  Pubblicazione: (2016)
• Potentially preventable tuberculosis among HIV-infected persons in the era of highly active antiretroviral treatment
  di: Pettit, A. C., et al.
  Pubblicazione: (2009)
• Antiretroviral Therapy Initiation Before, During, or After Pregnancy in HIV-1-Infected Women: Maternal Virologic, Immunologic, and Clinical Response
  di: Melekhin, Vlada V., et al.
  Pubblicazione: (2009)
• Race and Sex Differences in Antiretroviral Therapy Use and Mortality among HIV-Infected Persons in Care
  di: Lemly, Diana C., et al.
  Pubblicazione: (2009)
• Estimating the Optimal CD4 Count for HIV-infected Persons to Start Antiretroviral Therapy
  di: Shepherd, Bryan E., et al.
  Pubblicazione: (2010)